Comments
Loading...

Zomedica

ZOMAMEX
Logo brought to you by Benzinga Data
$0.147900
0.00795.64%
At close: -
$0.149500
0.00161.08%
After Hours: 7:59 PM EDT
Q3 2024 Earnings were released on Thu Nov 7th, after the market close
The most recent conference call was at 16:30 PM, 7 days ago Click to view past webcast
Consensus Rating1
Buy
Highest Price Target1
$6.00
Lowest Price Target1
$6.00
Consensus Price Target1
$6.00

Zomedica (AMEX:ZOM) Stock, Analyst Ratings, Price Targets, Forecasts

Zomedica Corp has a consensus price target of $6 based on the ratings of 1 analysts. The high is $6 issued by Dawson James on January 6, 2023. The low is $6 issued by Dawson James on January 6, 2023. The 1 most-recent analyst ratings were released by Dawson James on January 6, 2023, respectively. With an average price target of $6 between Dawson James, there's an implied 3913.38% upside for Zomedica Corp from these most-recent analyst ratings.

Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Dawson James

1calculated from analyst ratings

Analyst Ratings for Zomedica

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Zomedica (ZOM) stock?

A

The latest price target for Zomedica (AMEX:ZOM) was reported by Dawson James on January 6, 2023. The analyst firm set a price target for $6.00 expecting ZOM to rise to within 12 months (a possible 3913.38% upside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Zomedica (ZOM)?

A

The latest analyst rating for Zomedica (AMEX:ZOM) was provided by Dawson James, and Zomedica initiated their buy rating.

Q

When was the last upgrade for Zomedica (ZOM)?

A

There is no last upgrade for Zomedica

Q

When was the last downgrade for Zomedica (ZOM)?

A

There is no last downgrade for Zomedica.

Q

When is the next analyst rating going to be posted or updated for Zomedica (ZOM)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zomedica, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zomedica was filed on January 6, 2023 so you should expect the next rating to be made available sometime around January 6, 2024.

Q

Is the Analyst Rating Zomedica (ZOM) correct?

A

While ratings are subjective and will change, the latest Zomedica (ZOM) rating was a initiated with a price target of $0.00 to $6.00. The current price Zomedica (ZOM) is trading at is $0.15, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.